IDenta Corp. (OTCPK Exchange: IDTA)
Headquartered in Israel, IDenta is one of the world’s leading developers of point-of-care test kits for illicit drugs and explosives, and they are believed to be the only company in the world with a fully-developed R&D department devoted to this forensic industry. Corporate Profile >

Integrated Management Information, Inc. (OTC BB: INMG)
The company can provide ranchers, feed yards, processors, packers and retailers with complete verification and identification services which are necessary for many of the product certifications in the United States and abroad. Corporate Profile >

Amylin Pharmaceuticals, Inc. (AMLN:NASDAQ)
Amylin Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, cardiovascular disease and other metabolic diseases.   View Gold Star Report >

IDenta Corp. - July 18, 2008 -
(IDTA: OTC PK)

JERUSALEM -- (MARKET WIRE) -- The CEO of IDenta Corp. today issued a comprehensive statement concerning recent unauthorized promotional activities it believes are being conducted by a small number of financial agencies and short-term stock speculators. The company believes that these actions have both damaged its reputation and unrightfully depreciated the value of the company's stock. In the statement IDenta reiterated that sales of the company's products are steadily increasing (since beginning of 2007), that numerous new products are in development (precursors), that the company remains and will continue to be financially strong and that its worldwide partnerships are fully committed to the long-term success of IDenta Corp. (All of the partnership companies have and continue to invest substantial funds in marketing).

Today's statement reads:

  Continue here for further news >